Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?
- Published in:
- Clinical Cardiology, 2004, v. 27, n. S4, p. 3, doi. 10.1002/clc.4960271603
- By:
- Publication type:
- Article
Works matching IS 01609289 AND DT 2004 AND VI 27 AND IP S4
Results: 5
1
2
Introduction.
- Published in:
- Clinical Cardiology, 2004, v. 27, n. S4, p. 1, doi. 10.1002/clc.4960271602
- By:
- Publication type:
- Article
3
What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance?
- Published in:
- Clinical Cardiology, 2004, v. 27, n. S4, p. 11, doi. 10.1002/clc.4960271604
- By:
- Publication type:
- Article
4
Masthead.
- Published in:
- Clinical Cardiology, 2004, v. 27, n. S4, p. fmi, doi. 10.1002/clc.4960271601
- Publication type:
- Article
5
Imaging and peroxisome proliferator-activated receptor agonists: Uncovering their role in atherosclerosis development.
- Published in:
- Clinical Cardiology, 2004, v. 27, n. S4, p. 17, doi. 10.1002/clc.4960271605
- By:
- Publication type:
- Article